147 related articles for article (PubMed ID: 7545211)
21. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population.
Müller M; Viscidi RP; Ulken V; Bavinck JN; Hill PM; Fisher SG; Reid R; Munoz N; Schneider A; Shah KV
J Invest Dermatol; 1995 Jan; 104(1):138-41. PubMed ID: 7798632
[TBL] [Abstract][Full Text] [Related]
22. Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls.
Hamsiková E; Novák J; Hofmannová V; Munoz N; Bosch FX; de Sanjosé S; Shah K; Roth Z; Vonka V
J Infect Dis; 1994 Dec; 170(6):1424-31. PubMed ID: 7995981
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes.
Heino P; Skyldberg B; Lehtinen M; Rantala I; Hagmar B; Kreider JW; Kirnbauer R; Dillner J
J Gen Virol; 1995 May; 76 ( Pt 5)():1141-53. PubMed ID: 7537325
[TBL] [Abstract][Full Text] [Related]
24. A two-site enzyme immunoassay for quantitation of human papillomavirus type 16 particles.
Eklund C; Dillner J
J Virol Methods; 1995 May; 53(1):11-23. PubMed ID: 7635919
[TBL] [Abstract][Full Text] [Related]
25. Antibody response to a synthetic peptide derived from the human papillomavirus type 6/11 L2 protein in recurrent respiratory papillomatosis: correlation between Southern blot hybridization, polymerase chain reaction, and serology.
Tachezy R; Hamsikova E; Valvoda J; Van Ranst M; Betka J; Burk RD; Vonka V
J Med Virol; 1994 Jan; 42(1):52-9. PubMed ID: 8308521
[TBL] [Abstract][Full Text] [Related]
26. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system.
Touze A; El Mehdaoui S; Sizaret PY; Mougin C; Muñoz N; Coursaget P
J Clin Microbiol; 1998 Jul; 36(7):2046-51. PubMed ID: 9650960
[TBL] [Abstract][Full Text] [Related]
27. Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins.
Beiss BK; Heimer E; Felix A; Burk RD; Ritter DB; Mallon RG; Kadish AS
Virology; 1991 Sep; 184(1):460-4. PubMed ID: 1714667
[TBL] [Abstract][Full Text] [Related]
28. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames.
Dillner J; Dillner L; Utter G; Eklund C; Rotola A; Costa S; DiLuca D
Int J Cancer; 1990 Mar; 45(3):529-35. PubMed ID: 1689705
[TBL] [Abstract][Full Text] [Related]
29. Epitope mapping of the human papillomavirus type 16 E4 protein by means of synthetic peptides.
Suchánková A; Krchnák V; Vágner J; Hamsíková E; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1992 Feb; 73 ( Pt 2)():429-32. PubMed ID: 1371544
[TBL] [Abstract][Full Text] [Related]
30. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release.
Steele JC; Roberts S; Rookes SM; Gallimore PH
J Virol; 2002 Jun; 76(12):6027-36. PubMed ID: 12021335
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of HPV-DNA and anti-HPV antibodies in women from Girardot, Colombia.
Leon S; Sánchez R; Patarroyo MA; Camargo M; Mejia A; Urquiza M; Patarroyo ME
Sex Transm Dis; 2009 May; 36(5):290-6. PubMed ID: 19295467
[TBL] [Abstract][Full Text] [Related]
32. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
[TBL] [Abstract][Full Text] [Related]
33. Serological and T-helper cell responses to human papillomavirus type 16 L1 in women with cervical dysplasia or cervical carcinoma and in healthy controls.
Luxton JC; Rose RC; Coletart T; Wilson P; Shepherd PS
J Gen Virol; 1997 Apr; 78 ( Pt 4)():917-23. PubMed ID: 9129666
[TBL] [Abstract][Full Text] [Related]
34. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
Hernandez BY; Ton T; Shvetsov YB; Goodman MT; Zhu X
Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men.
Hagensee ME; Kiviat N; Critchlow CW; Hawes SE; Kuypers J; Holte S; Galloway DA
J Infect Dis; 1997 Sep; 176(3):625-31. PubMed ID: 9291307
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products.
Köchel HG; Sievert K; Monazahian M; Mittelstädt-Deterding A; Teichmann A; Thomssen R
Virology; 1991 Jun; 182(2):644-54. PubMed ID: 1850922
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with detection of human papillomavirus E4 and L1 proteins in condylomata acuminata.
Brown DR; Bryan JT; Rodriguez M; Katz BP
J Infect Dis; 1992 Sep; 166(3):512-7. PubMed ID: 1323617
[TBL] [Abstract][Full Text] [Related]
39. Epitope-mapped monoclonal antibodies against the HPV16E1--E4 protein.
Doorbar J; Ely S; Coleman N; Hibma M; Davies DH; Crawford L
Virology; 1992 Mar; 187(1):353-9. PubMed ID: 1371027
[TBL] [Abstract][Full Text] [Related]
40. Production of recombinant virus-like particles from human papillomavirus types 6 and 11, and study of serological reactivities between HPV 6, 11, 16 and 45 by ELISA: implications for papillomavirus prevention and detection.
Touzé A; Dupuy C; Mahé D; Sizaret PY; Coursaget P
FEMS Microbiol Lett; 1998 Mar; 160(1):111-8. PubMed ID: 9495021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
